Seed manufacturing major Monsanto has announced that it has rejected a $62 billion takeover offer from pharmaceuticals and chemicals firm Bayer, adding, it is open to further deal talks. Bayer's offer does not "adequately address or provide reassurance for some of the potential financing and regulatory execution risks" related to the deal, the company's CEO Hugh Grant said. 